Natural killer (NK) cells constitute a distinct lineage of lymphocytes that kill a variety of target cells, including tumor cells, cells infected with some viruses or bacteria, and some normal cell types. NK cells resemble cytotoxic T lymphocytes (CTLs) in some respects, including cytokine production and the use of the perforin-dependent cytolytic machinery. Significantly, however, NK cells do not express T cell receptors or immunoglobulins, and they are apparently unaffected by defects in the V-D-J recombination machinery. Furthermore, early efforts to define discrete patterns of recognition by NK cells met with failure, leading to the notion that NK recognition is "primitive." However, recent results suggest that target cell lysis by NK cells is regulated by a balance between specific activating and inhibitory receptors. A major component of recognition involves receptors specific for class I major histocompatibility complex (MHC) molecules on target cells, engagement of which inhibits N K lysis. Thus, cells exhibiting abnormal or reduced amounts of class I molecules, which are therefore invisible to CTLs, are killed by NK cells. The recent characterization of several novel recognition structures on NK cells has added a wealth of new information, but at the same time has generated a number of fascinating puzzles.
Recognition of Class I MHC Molecules by NK Cells
The role of NK ceils in bone marrow allograft rejection was the initial hint that they recognize MHC molecules (for review see Yu et al., 1992) . Then it was discovered that the sensitivity of many tumor cells to lysis by NK cells in vitro is inversely related to the levels of MHC class I molecules on the tumor cells (for review see Ljunggren and Karre, 1990) , a finding later extended to nontransformed lymphoblasts from class I-deficient mice (Liao et al., 1991) . Class I molecules on target cells somehow prevent NK cell-mediated lysis.
The situation proved more complex when it was appreciated that NK cells can discriminate class I alleles. Human NK clones were shown to lyse allogeneic T cell blasts, and the target cell genes controlling susceptibility to lysis were mapped to the MHC (Ciccone et al., 1992) . In the murine system, an NK cell subset defined by expression of the Ly49A moleculewas shown to discriminate between tumor target cells expressing different MHC haplotypes (Karlhofer et al., 1992) . Class I Expression by Target Cells Inhibits NK Cells and Activates T Cells Fragments of intracellular protein antigens are presented by MHC class I molecules on the cell surface. Hence, class I molecules allow specific recognition and lysis of infected Minireview cells by CTLs. NK cells behave in exactly the opposite fashion, in that expression of class I genes generally renders target cells resistant to lysis (Storkus et al., 1989; Ljunggren and Karre, 1990; Karlhofer et al., 1992) . Why should NK cell lysis be inhibited by class I molecules expressed on target cells? The obvious possibility is that a key function of NK cells is to monitor the integrity of class I expression. Repression of class I expression either directly or via the class I antigen processing pathway is a strategy employed by many viruses to hide from CTLs within infected cells. Similarly, metastatic tumor cells often exhibit repressed class I expression, perhaps owing to selection by CTLs. Repression of class I expression by any mechanism would in most cases render cells sensitive to lysis by NK cells. Thus, the development of a monitoring system for class I expression makes sense evotutionarily.
Identification of Class I-Specific Inhibitory Receptors on NK Cells
The general consensus is that class I inhibition of NK cells is accomplished by class I-specific NK cell receptors, which transduce signals that inhibit the lytic machinery (Figure 1 ). The recent identification of putative MHC class I-specific receptors on NK cells in both the murine and human systems supports this view. In the murine system, the Ly49A molecule defines a subset of 10%-20% of NK cells that lyses cells of the H-2 ~ MHC haplotype, but not cells expressing the D d MHC class I gene (Karlhofer et al., 1992) . Furthermore, Ly49A binds to the D a molecule (Kane, 1994; Daniels et al., 1994a) . Blocking either Ly49A or D d with antibodies prevents inhibition of NK cell lysis, suggesting that Ly49A represents a Da-specific inhibitory NK receptor.
In the human system, several monoclonal antibodies reactive to the p58 family of cell surface receptors define NK cell subsets that exhibit distinct human lymphocyte antigen (HLA) (human MHC) specificities. For example, NK clones that stain with the GL183 anti-p58 antibody are specifically inhibited by target cells expressing HLA-Cw3 and related alleles (Moretta et al., 1993) , and those that
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Receptor Ligand (Litwin et al., 1994; D'Andrea et al., 1995) . Antibodies against either the p58 receptor or the corresponding HLA molecule restore lysis of cells expressing the inhibitory HLA allele. While binding of p58 molecules to class I molecules has not been reported, the results seem to parallel the mouse data in other respects. Surprisingly, however, the p58 receptors and the Ly49 receptors are about as dissimilar in structure as cell surface receptors can be.
Structure and Expression of Ly49 and p58 NK Cell Receptors
Ly49A is a disulfide-linked dimeric glycoprotein of 44 kDa subunits (Figure 2 ). The cDNA sequence indicated that Ly49A is a type II membrane glycoprotein and that a major segment of the extracellular domain exhibits homology to the C-type lectin super family (Yokoyama and Seaman, 1993) . Indeed, recent evidence suggests that glycans on D d class I molecules contribute to the interaction with Ly49A (Daniels et al., 1994b) , though the discrimination of class I alleles by Ly49A suggests interactions with the class I polypeptide chain as well. At least seven additional related cDNAs were isolated by hybridization with Ly49A cDNA, defining a small family of NK cell receptor genes closely linked on mouse chromosome 6. Interestingly, Ly49 genes undergo allelic exclusion in NK cells, consistent with an important role of these receptors in mediating specific NK cell recognition (Held et al., 1995) . Three Ly49 family members with distinct specificities were defined with monoclonal antibodies (Karlhofer et al., 1992; Stoneman et al., 1995; Mason et al., 1995) . These receptors are expressed on distinct but overlapping NK cell subsets, together accounting for more than 75% of NK cells. These findings suggest that Ly49 receptors are expressed by most, if not all, NK cells. In contrast, the sequences of the newly cloned human p58 receptors suggest they are type I membrane glycoproteins and members of the immunoglobulin superfamily (Wagtmann et al., 1995; Colonna and Samaridis, 1995) (Figure 2 ). The distinct structures of p58 and Ly49 receptors account for earlier findings that p58 receptors are larger (58 kDa) th an Ly49 molecules and are not covalently dimerized. Furthermore, p58 genes map to chromosome 19, nonsyntenic to Ly49 genes.
Like the Ly49 family, the p58 receptors represent a family of proteins. At least nine distinct but related sequences have been deduced from cDNA sequencing, though some of these may represent alleles. Gene expression studies indicated that every NK cell clone examined expressed one or more p58 receptor.
Too Many Receptors?
If until recently NK cell receptors were too few, now there seems to be too many. Currently, p58 receptors have not been identified in the mouse. While NK-specific type II lectin-like membrane proteins have been identified on human NK cells, there is presently no agreement that these receptors represent human Ly49 homologs Yabe et al., 1993) . It seems unlikely, however, that the p58 and Ly49 receptor families arose so late in evolu- (Yokoyama and Seaman, 1993; Bennett et al., 1995; Mason et al., 1995) , suggesting that this class of molecules does not discriminate between different class I loci.
Another possibility is that the two receptor families are functionally redundant. However, while examples have been reported of clones expressing two functional p58 receptors with different HLA specificities, it would seem counterproductive for NK cells generally to express receptors for more than one self class I molecule: these cells would be unable to lyse target cells that had extinguished expression of only one of the class I molecules. Furthermore, the inhibition of lysis caused by transfected class I genes in target cells can often be reversed by antibodies against a single p58 or Ly49 receptor, suggesting that these NK cells may not express other receptors with the same class I specificity. The present data are not incompatible with the existence of NK clones in which members of both receptor families are functionally active, but it remains unclear how the activities of the two receptor families would be coordinated.
Discrimination of Class I-Bound Peptides by NK Cells?
Class I molecules on cells are complexed with many different cellular peptides. If class I-specific NK cell receptors recognize only specific peptide-class I complexes, target cells could be rendered NK sensitive by displacement of the relevant peptides by viral antigens as well as by class I repression. Peptide-transporter-deficient cell lines were used to assess the peptide specificity of class I recognition by NK cells. Whereas the murine Ly49A ÷ NK subset failed to discriminate different peptides bound to D d (Correa and Raulet, 1995) , two examples of human NK clones were described that appear to discriminate B27-bound peptides . Further studies will be necessary to resolve whether this reflects the use of the different receptor families or some other experimental differences.
Isoforms of p58.Related Receptors Suggest Functional Heterogeneity
The cDNA sequences of p58-related receptors reveal two forms of length heterogeneity (Wagtmann et al., 1995; CoIonna and Samaridis, 1995) (Figure 2 ). In the extracellular domain, some of the sequences contain two immunoglobulin loops, whereas others contain three immunoglobulin loops. The sequences containing two immunoglobulin loops presumably encode the 58 kDa receptors, whereas a sequence containing three immunoglobulin loops encodes the previously described 70 kDa inhibitory receptor defined by the anti-NKB1 monoclonal antibody (D'Andrea et al., 1995) . At present, the significance of this heterogeneity is unclear.
On the other hand, heterogeneity observed in the transmembrane regions and cytoplasmic tails may account for putative signaling differences by p58-related isoforms. Seven of the published sequences have cytoplasmic tails of 76 or 84 amino acids, containing two YxxL sequences characteristic of antigen receptor activation motifs (ARAMs) found in antigen receptor-associated molecules such as the CD3 chains. However, the p58 YxxL sequences are separated by 26 amino acids rather than the 6-8 amino acids found in CD3 chains. The difference in spacing may contribute to the different signaling properties of CD3 chains (activation) versus p58 receptors (inhibition). Interestingly, two of the p58-1ike sequences contain a shorter (39 amino acid) cytoplasmic tail, lacking the ARAM-like sequences, raising the possibility that these receptors may signal differently.
In fact, evidence from the mouse, rat, and human systems suggests that MHC molecules on target cells may sometimes activate rather than inhibit lysis. Recently, a shorter (50 kDa) version of the p58 receptor was identified that apparently mediates class I-specific NK cell activation . It is thus tempting to speculate that activating receptors belong to the p58-related receptor family but contain the shorter cytoplasmic tails described above. Interestingly, the sequences with the shorter cytoplasmic tails contain charged (lysine) residues in their transmembrane region. By analogy with T cell receptors, the lysine residues may pair with other activating molecules such as CD3 chains. While the structural heterogeneity of p58-related receptors may account for their distinctive functional heterogeneity, at present it is entirely unclear why NK cells should have evolved the capacity to destroy cells expressing specific class I molecules.
Other Activating Receptors for NK Cells?
The role of class I-specific activating receptors on NK cells is obscure, but the existence of activating receptors specific for tumor cells has long been predicted. The NKR-P1 proteins (Chambers et al., 1989) are encoded by a small family of related genes that are closely linked to Ly49 and also encode type II membrane proteins with lectin domains (Yokoyama and Seaman, 1993) . Recently, evidence has accumulated that NKR-P1 proteins participate in activating the lysis of some (but probably not all) tumor cells (Bezouska et al., 1994; Ryan et al., 1995) , possibly by interacting with oligosaccharide ligands (Figure 2) . Additionally, Fc receptors on NK cells mediate cytotoxicity of antibody-coated target cells. Importantly, engagement of inhibitory receptors can often overrule the activating signals, suggesting that the outcome of an NK cell-target cell interaction may be determined by the balance of the two types of signals.
Outstanding Questions
While great progress has been made in the field of NK cell specificity, many new questions are prompted by the recent results. Are both the Ly49 and p58 inhibitory receptor families present in the same species? If so, are their specificities distinct, and how are their activities coordinated in individual NK cells? What are the mechanisms that distribute expression of different class I receptors to distinct (though overlapping) subsets, resulting in the formation of the NK repertoire? How are potentially autoaggressive NK clones silenced? What is the funclion of putative activating class I-specific NK receptors? What signal transduction pathways are employed by the inhibitory receptors? Finally, are NK cells really so primitive? If the chief function of the class I inhibitory system is to monitor the integrity of class I expression and if class I molecules function primarily to present antigens to T cells, the class I inhibitory receptors may have evolved after the T cell system and not before. Are NK cells modern, or do the class I inhibitory receptors represent recently added equipment to an ancient cell type?
